Key result
Residence in low to lower-middle-income countries was associated with higher 30-day mortality in NSTEMI patients compared to high-income countries.
Why the study?
The majority of the NSTEMI burden resides outside high-income countries, but presentation, care, and outcomes across country income classifications remained to be described.
Does country income classification affect the presentation, quality of care, and clinical outcomes of patients with NSTEMI?
Cohort (n=2,947)
Yes
Does country income classification affect the presentation, quality of care, and clinical outcomes of patients with NSTEMI?
Patients with NSTEMI in lower-income countries present with more advanced acute disease and experience significantly higher in-hospital and 30-day mortality compared to those in high-income countries.
Answers are grounded in this paper and cite their sources.
NSTEMI patients in lower-income countries had higher mortality and complications despite similar care quality; leaves open targeted strategies to address inequities.
BACKGROUND: The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification. METHODS AND RESULTS: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank country income classification. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included in-hospital acute heart failure, stroke/transient ischaemic attack, and death, and 30-day mortality. Patients admitted with NSTEMI in low to lower-middle-income countries (LLMICs), compared with patients in HICs, were younger, more commonly diabetic, and current smokers, but with a lower burden of other comorbidities, and 76.7% met very high risk criteria for an immediate invasive strategy. Invasive coronary angiography use increased with ascending income classification (LLMICs, 79.2%; upper middle income countries [UMICs], 83.7%; HICs, 91.0%), but overall care quality did not (≥80% of eligible interventions achieved: LLMICS, 64.8%; UMICs 69.6%; HICs 55.1%). Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day mortality (LLMICs, 4.9%; UMICs, 3.9%; HICs, 1.5%; P < 0.001) exhibited an inverse economic gradient. CONCLUSION: Patients with NSTEMI in LLMICs present with fewer comorbidities but a more advanced stage of acute disease, and have worse outcomes compared with HICs. A cardiovascular health narrative is needed to address this inequity across economic boundaries.
No takes yet. Share an insight, caveat, or question.
Nadarajah et al. (2023) conducted a cohort in NSTEMI (n=2,947). Residence in low to lower-middle-income countries (LLMICs) vs. Residence in high-income countries (HICs) was evaluated on 30-day mortality (p=< 0.001). Residence in low to lower-middle-income countries was associated with higher 30-day mortality in NSTEMI patients compared to high-income countries.
Synapse has enriched 10 related papers. Consider them for comparative context: